Uffe K Jensen Email & Phone Number

Copenhagen, Dk

Copenhagen, Capital Region Of Denmark, Dk

Chief Executive Officer at Specific Pharma A/S. As CEO and Managing Director at Specific Pharma A/S, a leading pharmaceutical specialty company and part of the Phoenix Group, I lead operations across Denmark, Sweden, Norway, the Baltics, and the Netherlands. I work closely with healthcare professionals, pharmaceutical companies, health authorities, and patients to ensure timely access to critical medicines and drive growth across the Nordics.My Role & Responsibilities:Strategic Leadership: I oversee the company’s strategic direction, operations, and day-to-day management of leaders and team members across:Commercial, Purchasing, Logistics, Supply Chain, Quality Assurance, Medical Affairs, Clinical Trial Supply Management, and Warehousing.P&L Management: Full responsibility for Profit & Loss, financial performance, budgeting, and reporting to the Board, ensuring transparency and accountability.Operational Excellence: I ensure that all company activities comply with regulations, governance, and industry standards, delivering operational efficiency and business success.Cross-Functional Expertise: By combining my deep industry knowledge and hands-on leadership, I ensure seamless collaboration across departments to meet business goals and deliver value to our stakeholders.What Drives Me:I am passionate about leading teams to success, fostering a culture of collaboration and high performance, and ensuring that patients across the Nordics receive access to essential treatments. My leadership philosophy balances strategic vision with operational execution, always with a focus on delivering measurable results.

Switzerland 🇨🇭 , Ch

Primary responsibilities Leadership:Leading three Disease Area Teams: Breast Cancer, Pulmonary & Rare Diseases• Marketing, Sales, Medical Affairs, Market Access and External Affairs• Managing, coaching and developing direct reportsStrategy & Planning• Delivers cross-functional lifecycle Disease Area Plan• Ensuring overall Product Vision is translated into strategy • Review, Challenge and validate Brand plans, Tactical Plans and Account Plans, ensuring alignment with global strategies• Pipeline products: Ensuring development of Pre-Brand plans in alignment with global strategies• Ensuring Institutional Readiness for new launches in due timeFinancialOwns Disease Area strategy and P&L and drives resource allocation within budget• Commercial cost management for Denmark and IcelandImplementation• Ensure timely implementation of all cross-functional tactics with excellence standards that complies with legislation and ethical standards

Tel-Aviv, Il

Head of Marketing, Market Access and Sales. Full P&L responsibility for all activities including product management, field based activities, budgeting and other business unit operations. Responsible for the following functions:• Business strategy • Market Access • Marketing and product launch• Sales and Key Account Management

Tokyo, Jp

Director of the Danish market with the overall P&L responsibility. Head of the Rx division which is Takeda's division for all branded and promoted drugs. Member of the Danish management team. Responsible for the following functions:• Sales and Key Account Management• Marketing• Market Access and Health Economics

Cambridge, Massachusetts, Us

Head of the GP division, reporting directly to the Managing Director. Main role was leadership and management and I was responsible for both sales and marketing activities. I was responsible for achieving the financial targets (top and bottom line) in accordance with Nycomed's strategies and values.

Zurich, Ch

I was responsible for the GP division, where the primary focus was sales to the GP sector. The division was the largest in Nycomed, and was the division where Nycomed's branded prescription products to the GP sector was located.

New York, New York, Us

In a new position, I was given the responsibility to create and develop a new separate sales unit for the drug Enbrel. (Rheumatology and dermatology) I was responsible for sales of Enbrel which was Denmark's fifth largest drug. I was responsible for 6 hospital product specialists and 2 instruction nurses.I was responsible for the development of the dermatological strategy for Enbrel in the field of psoriasisTasks and key roles:• Leadership - including coaching, sales training, development and employment of new people• Sales - including sales strategy, sales tactics, budgeting / tracking and analysis• PR and PA - including building KAM relationships and contacts with policy makers at county and regional level• I was also responsible for the selection of hospitals for clinical studies in the therapeutic area

New York, New York, Us

In this position I was responsible for bringing together the entire Pfizer pain portfolio as a whole. The pain portfolio consisted of 12 pain products from Ketogan to Treo.I created a synergy and secured a market leadership in pain management in Denmark. My strategic initiatives to address this challenge were so good that I was chosen for this year's Brand Manager 2005 Pfizer.

New York, New York, Us

During this time period, I had two roles. One, as Team Leader and one, as a traditional product manage with responsibility for four of Pfizer's CNS products.As Brand leader, I had the overall responsibility for Lyrica Brand team and the most important task was to ensure a successful launch of Lyrica in Denmark and Iceland. This launch was one of Denmark's best product launches ever measured in terms of knowledge, share of voice and activity level. I had management responsibility for the team which consisted of sales manager, medical advisor, health economist, marketing assistant, and registration boss. Moreover, I had the professional- and educational responsibilities of a consultant force of 25 consultants and 7 product specialists

Brentford, Middlesex, Gb

In this period, I had the responsibility for Imigran (for the treatment of migraine). I helped to cultivate and develop the migraine market in Denmark and led Imigran forward to becoming GW’s largest product with a total turnover of approx. DKK 131 mio. This turnover made Imigran the 2 largest product in Denmark. I had the professional and educational responsibility for 6 GP’s and 2 product specialists

Brentford, Middlesex, Gb

Customer Group was general practitioners, specialists and pharmacies in the South and West Zealand. I was responsible for sales of the following products: Zantac (antacids), Ventolin & Serevent (asthma medication), Beconase (hay fever medicine)

Executive Public Affairs

Mini Mba

Pharmaceutical Marketing And Management, Internal Pfizer Course - Top Performer Programme

Bachelor, Business Administration

Ba, International Marketing

Nurse